Costello S M, Felix R T, Giese R W
Clin Chem. 1979 Sep;25(9):1572-80.
Classically, one can increase the titer of an agglutinating or first antibody with an antiglobulin or second antibody. We have used an avidin-biotin system in place of antiglobulin to similarly extend the agglutination by an initial anticellular antibody. Erythrocytes were agglutinated by adding in succession, caproylamidobiotin-antibody, avidin, and extender (caproylamidobiotin-macromolecule). The macromolecules evaluated as extenders, in order of increasing potency, were fibrinogen, albumin, succinylated polylysine, and ribonuclease A. From comparative testing, we found that antiglobulin raised the titer of antibody from 2560 to 20,480, and the avidin-biotin tool raised the titer of caproylamidobiotin-antibody from 2560 to 10,240 without extender and to 81,820 with an extender of caproylamidobiotin-ribonuclease. Thus noncovalent extenders add to the capability of the avidin-biotin system to facilitate and substitute for an antibody.
传统上,可以使用抗球蛋白或第二抗体来提高凝集性抗体或第一抗体的效价。我们使用抗生物素蛋白-生物素系统替代抗球蛋白,以类似地通过初始抗细胞抗体来扩展凝集反应。通过依次加入己酰氨基生物素-抗体、抗生物素蛋白和扩展剂(己酰氨基生物素-大分子)使红细胞发生凝集。作为扩展剂进行评估的大分子,按效力递增顺序依次为纤维蛋白原、白蛋白、琥珀酰化聚赖氨酸和核糖核酸酶A。通过比较测试,我们发现抗球蛋白将抗体效价从2560提高到20480,而抗生物素蛋白-生物素工具在没有扩展剂的情况下将己酰氨基生物素-抗体的效价从2560提高到10240,在使用己酰氨基生物素-核糖核酸酶作为扩展剂时提高到81820。因此,非共价扩展剂增加了抗生物素蛋白-生物素系统促进和替代抗体的能力。